28 articles for thisTarget
              
              The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin.

Institute For Infection Research
 
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite.

Glaxosmithkline
 
Nitro as a novel zinc-binding group in the inhibition of carboxypeptidase A.

Yanbian University
 
Discovery and synthesis of namalide reveals a new anabaenopeptin scaffold and peptidase inhibitor.

National Institute of Diabetes and Digestive and Kidney Diseases
 
Characterization of alpha-nitromethyl ketone as a new zinc-binding group based on structural analysis of its complex with carboxypeptidase A.

Yanbian University
 
A new type of five-membered heterocyclic inhibitors of basic metallocarboxypeptidases.

Universitat Aut£Noma De Barcelona
 
 
Inhibition of carboxypeptidase a by N-(4-
t-Butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone

TBA
 
 
The function of S
1′ subsite pocket of carboxypeptidase A

TBA
 
 
The structural feature of S
1′ subsite of carboxypeptidase A

TBA
 
Cyclobutane-containing peptides: evaluation as novel metallocarboxypeptidase inhibitors and modelling of their mode of action.

Universitat AutòNoma De Barcelona
 
Thioxophosphoranyl aryl- and heteroaryloxiranes as the representants of a new class of metallocarboxypeptidase inhibitors.

Universitat AutòNoma De Barcelona
 
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1' modifications for the exploration of the S1' subsite.

Glaxosmithkline
 
Discovery of potent& selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor for the treatment of thrombosis.

Pfizer
 
Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin-activatable fibrinolysis inhibitor as novel antithrombotics.

Merck Research Laboratories
 
Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.

Pohang University of Science and Technology
 
Discovery of anabaenopeptin 679 from freshwater algal bloom material: Insights into the structure-activity relationship of anabaenopeptin protease inhibitors.

University of California Santa Cruz
 
Cysteine derivatives as inhibitors for carboxypeptidase A: synthesis and structure-activity relationships.

Pohang University of Science and Technology
 
Effect of zinc ion on the inhibition of carboxypeptidase A by imidazole-bearing substrate analogues.

Pohang University of Science and Technology
 
Synthesis and Structural/Functional Characterization of Selective M14 Metallocarboxypeptidase Inhibitors Based on Phosphinic Pseudopeptide Scaffold: Implications on the Design of Specific Optical Probes.

Universitat Aut£Noma De Barcelona
 
First hydroxamate inhibitors for carboxypeptidase A. N-acyl-N-hydroxy-beta-phenylalanines.

Pohang University of Science and Technology
 
Biological activity of tropolone.

Osaka Organic Chemical Industry
 
Homotyrosine-containing cyanopeptolins 880 and 960 and anabaenopeptins 908 and 915 from Planktothrix agardhii CYA 126/8.

University of Hawaii
 
New anabaenopeptins, potent carboxypeptidase-A inhibitors from the cyanobacterium Aphanizomenon flos-aquae.

The University of Tokyo
 
Discovery of Mechanism-Based Inactivators for Human Pancreatic Carboxypeptidase A from a Focused Synthetic Library.

University of Notre Dame
 
Namalides B and C and Spumigins K-N from the Cultured Freshwater Cyanobacterium Sphaerospermopsis torques-reginae.

University of S£O Paulo
 
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Array Biopharma
 
Novel inhibitors of the v-raf murine sarcoma viral oncogene homologue B1 (BRAF) based on a 2,6-disubstituted pyrazine scaffold.

Cancer Research Uk Centre For Cancer Therapeutics
 
Anilinopyrazole as selective CDK2 inhibitors: design, synthesis, biological evaluation, and X-ray crystallographic analysis.

Glaxosmithkline